ATAI
Price
$1.97
Change
+$0.04 (+2.07%)
Updated
Apr 29, 6:59 PM EST
13 days until earnings call
COUR
Price
$11.88
Change
-$0.10 (-0.83%)
Updated
Apr 29, 6:59 PM EST
86 days until earnings call
Ad is loading...

Compare predictions ATAI vs COUR

Header iconATAI vs COUR Comparison
Open Charts ATAI vs COURBanner chart's image
ATAI Life Sciences
Price$1.97
Change+$0.04 (+2.07%)
Volume$597.82K
CapitalizationN/A
Coursera
Price$11.88
Change-$0.10 (-0.83%)
Volume$1.43M
CapitalizationN/A
View a ticker or compare two or three
ATAI vs COUR Comparison Chart

Loading...

ATAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
COURDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATAI vs. COUR commentary
Apr 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and COUR is a Sell.

COMPARISON
Comparison
Apr 30, 2024
Stock price -- (ATAI: $1.97 vs. COUR: $11.89)
Brand notoriety: ATAI and COUR are both not notable
ATAI represents the Biotechnology, while COUR is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 63% vs. COUR: 265%
Market capitalization -- ATAI: $329.8M vs. COUR: $2.21B
ATAI [@Biotechnology] is valued at $329.8M. COUR’s [@Miscellaneous Commercial Services] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $4.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCOUR’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • COUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATAI and COUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 2 TA indicator(s) are bullish while COUR’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 2 bullish, 7 bearish.
  • COUR’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, COUR is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а +5.35% price change this week, while COUR (@Miscellaneous Commercial Services) price change was -2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.59%. For the same industry, the average monthly price growth was -6.46%, and the average quarterly price growth was +1250.58%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +1.76%. For the same industry, the average monthly price growth was +2.79%, and the average quarterly price growth was +20.45%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 12, 2024.

COUR is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Biotechnology (+5.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (+1.76% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
A.I.dvisor published
a Summary for ATAI with price predictions.
OPEN
A.I.dvisor published
a Summary for COUR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
COUR($2.21B) has a higher market cap than ATAI($330M). ATAI YTD gains are higher at: 39.716 vs. COUR (-38.616).
ATAICOURATAI / COUR
Capitalization330M2.21B15%
EBITDAN/A-129.13M-
Gain YTD39.716-38.616-103%
P/E RatioN/AN/A-
RevenueN/A636M-
Total CashN/A722M-
Total DebtN/A6.6M-
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICOUR
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
64%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 9 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ATAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
COURDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFDCX17.840.13
+0.73%
Hartford Schroders US MidCap Opps C
TSCSX30.310.18
+0.60%
Thrivent Small Cap Stock S
PCVCX9.320.04
+0.43%
Virtus NFJ Small-Cap Value C
VLCAX118.210.35
+0.30%
Vanguard Large Cap Index Admiral
PLABX36.98N/A
N/A
Plumb Balanced A

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with ALLO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+2.07%
ALLO - ATAI
48%
Loosely correlated
-1.73%
MNMD - ATAI
45%
Loosely correlated
+5.99%
COUR - ATAI
45%
Loosely correlated
-0.67%
VCYT - ATAI
45%
Loosely correlated
+5.33%
NTLA - ATAI
44%
Loosely correlated
+5.88%
More

COUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COUR has been loosely correlated with DNB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if COUR jumps, then DNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COUR
1D Price
Change %
COUR100%
-0.67%
DNB - COUR
48%
Loosely correlated
+0.21%
ARLO - COUR
46%
Loosely correlated
+2.46%
ATAI - COUR
45%
Loosely correlated
+2.07%
BCO - COUR
34%
Loosely correlated
+1.58%
UDMY - COUR
33%
Loosely correlated
+1.18%
More